XML 51 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information
 12 Months Ended
Dec. 31, 2014
Segment Information [Abstract]  
Segment Information
19.  Segment Information

The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China. In Mainland China, the Company utilizes sales employees, contractual sales promoters, independent direct sellers and independent marketers to distribute its products. Contractual sales promoters sell products in similar fashion to the Company's sales employees, but act as independent agents, to sell products through its retail stores and website. Independent direct sellers can sell away from the Company's stores where the Company has obtained a direct selling license to do so. Independent marketers are licensed business owners who are authorized to sell the Company's products either at their own approved premises or through the Company's stores. Selling expenses are the Company's largest expense comprised of the commissions paid to its worldwide independent distributors as well as remuneration to its sales force in Mainland China. The Company manages its business primarily by managing its sales force. The Company does not use profitability reports on a regional or divisional basis for making business decisions. However, the Company does report revenue in five geographic regions: Greater China, North Asia, Americas, South Asia/Pacific and EMEA.
 
Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):

  
Year Ended December 31,
 
Revenue:
 
2012
  
2013
  
2014
 
       
Greater China
 
$
550,690
  
$
1,363,182
  
$
948,523
 
North Asia
  
785,302
   
869,400
   
782,985
 
Americas
  
285,283
   
370,087
   
329,027
 
South Asia/Pacific
  
328,597
   
378,988
   
328,388
 
EMEA
  
182,385
   
195,061
   
180,572
 
Total
 
$
2,132,257
  
$
3,176,718
  
$
2,569,495
 

Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):

  
Year Ended December 31,
 
Revenue:
 
2012
  
2013
  
2014
 
       
Nu Skin
 
$
1,158,213
  
$
1,641,618
  
$
1,562,595
 
Pharmanex
  
966,572
   
1,529,211
   
1,000,279
 
Other
  
7,472
   
5,889
   
6,621
 
Total
 
$
2,132,257
  
$
3,176,718
  
$
2,569,495
 

Additional information as to the Company's operations in the most significant geographical areas is set forth below (U.S. dollars in thousands):

  
Year Ended December 31,
 
Revenue:
 
2012
  
2013
  
2014
 
       
Japan
 
$
489,302
  
$
402,580
  
$
315,265
 
Mainland China
  
256,833
   
1,005,395
   
675,082
 
South Korea
  
296,000
   
466,820
   
467,720
 
United States
  
227,872
   
268,232
   
230,767
 

  
December 31,
 
Long-lived assets:
 
2013
  
2014
 
     
Japan
 
$
9,970
  
$
13,768
 
Mainland China
  
82,726
   
103,445
 
South Korea
  
14,345
   
46,626
 
United States
  
273,388
   
287,103